Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1717-1722
Published online before print July 3, 2008, doi: 10.1161/ATVBAHA.108.163402
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/10/1717    most recent
ATVBAHA.108.163402v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasai, A.
Right arrow Articles by Baba, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasai, A.
Right arrow Articles by Baba, A.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1717.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Retardation of Retinal Vascular Development in Apelin-Deficient Mice

Atsushi Kasai; Norihito Shintani; Hideaki Kato; Satoshi Matsuda; Fumi Gomi; Ryota Haba; Hitoshi Hashimoto; Michiya Kakuda; Yasuo Tano; Akemichi Baba

From the Laboratory of Molecular Neuropharmacology (A.K., N.S., H.K., R.H., H.H., A.B.), Graduate School of Pharmaceutical Sciences, Osaka University, Japan; the Department of Pharmacotherapeutics (A.K.), Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan; and the Departments of Ophthalmology (S.M., F.G., Y.T.), and Experimental Disease Model, the Osaka-Hamamatsu Joint Research Center for Child Mental Development (H.H., M.K.), Graduate School of Medicine, Osaka University, Japan.

Correspondence to Akemichi Baba, PhD, 1-6, Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail baba{at}phs.osaka-u.ac.jp

Objective— Apelin is an endogenous ligand for the G protein-coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice.

Methods and Results— Apelin-KO mice showed impaired retinal vascularization and ocular development, which were analyzed by histology, immunohistochemistry, real-time polymerase chain reaction, and the mouse corneal micropocket assay. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis.

Conclusions— Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2, and contributes to normal ocular development.

To identify the roles of endogenous apelin, we investigated the phenotype of apelin-KO mice. Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2 and contributes to normal ocular development.


Key Words: apelin • VEGF • FGF2 • knockout mice • angiogenesis


Related Article:

Apelin-APJ Signaling in Retinal Angiogenesis
Yoko Kojima and Thomas Quertermous
Arterioscler. Thromb. Vasc. Biol. 2008 28: 1687-1688. [Extract] [Full Text] [PDF]